Abstract
2113 Initial safety survey report from early post-marketing phase vigilance (EPPV) on TAS-102 for metastatic colorectal cancer (mCRC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s0959-8049(16)31035-8
Journal: European Journal of Cancer | Publication Date: Sep 1, 2015 |
Citations: 1 |
2113 Initial safety survey report from early post-marketing phase vigilance (EPPV) on TAS-102 for metastatic colorectal cancer (mCRC)
Join us for a 30 min session where you can share your feedback and ask us any queries you have